Effect of vitamin D3on monocyte chemoattractant protein 1 production in monocytes and macrophages

Acta Cardiologica Sinica

Volumn 30, Issue 2, 2014, Pages 144-150

  Wang, Yi Chen ^a   Hsieh, Chong Chao ^b   Kuo, Hsuan Fu ^c   Tsai, Ming Kai ^a,d   Yang, San Nan ^c,e   Kuo, Chang Hung ^c,e,f   Lee, Min Sheng ^c,f   Hung, Chih Hsing ^c,e  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b Division of General Surgery   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

Chemokine; Monocyte; Monocyte chemoattractant protein 1 (MCP 1); P38; Vitamin D

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ASCORBIC ACID; COLECALCIFEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOL; SYNAPTOPHYSIN; VITAMIN D RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84898485485     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33.
2. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200-57.
3. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxy vitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101. (Pubitemid 41546218)
4. Takeda M, Yamashita T, Sasaki N, Hirata K. Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis. J Atheroscler Thromb 2012;19:953-61.
5. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
6. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80. (Pubitemid 351831400)
7. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. (Pubitemid 351930842)
8. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-23.
9. Kleinegris MC, Ten Cate-Hoek AJ, Ten Cate H. Coagulation and the vessel wall in thrombosis and atherosclerosis. Pol Arch Med Wewn 2012;122:557-66.
10. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl JMed 1998;338:436-45. (Pubitemid 28135672)
11. Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010;411:1570-9.
12. Matoba T, Egashira K. Anti-inflammatory gene therapy for cardiovascular disease. Curr Gene Ther 2011;11:442-6.
13. Villaggio B, Soldano S, Cutolo M. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin Exp Rheumatol 2012;30:934-8.
14. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94. (Pubitemid 32222977)
15. Itabe H. Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis. J Clin Biochem Nutr 2012;51:1-8.
16. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-41.
17. Ohman MK, Eitzman DT. Targeting MCP-1 to reduce vascular complications of obesity. Recent Pat Cardiovasc Drug Discov 2009;4:164-76.
18. Saggini A, Anogeianaki A, Angelucci D, et al. Cholesterol and vitamins: revisited study. J Biol Regul Homeost Agents 2011;25:505-15.
19. Riccioni G, D'Orazio N, Salvatore C, et al. Carotenoids and vitamins C and E in the prevention of cardiovascular disease. Int J Vitam Nutr Res 2012;82:15-26.
20. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106:963-8.
21. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke 2006;37:243-5. (Pubitemid 43732081)
22. Barakat K, Hitman GA. The emerging role of vitamin D and its receptor in the pathogenesis of acute coronary syndromes. Br J Cardiol 2006;13:9-12.
23. Chua GT, Chan YC, Cheng SW. Vitamin D status and peripheral arterial disease: evidence so far. Vasc Health Risk Manag 2011;7:671-5.
24. Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008;324:23-33. (Pubitemid 350294165)
25. Taher YA, van Esch BC, Hofman GA, et al. 1alpha, 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGFbeta. J Immunol 2008;180:5211-21.
26. Gregori S, Giarratana N, Smiroldo S, et al. A 1alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367-74. (Pubitemid 34826601)
27. + cells in the draining lymph nodes. J Immunol 2007;179:6273-83.
28. Vinikoor MJ, Napravnik S, Floris-Moore M, et al. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses 2013;29:1068-74.
29. Masiá M, Robledano C, Ortiz de la Tabla V, et al. Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients. PLoS One 2013;8:e64327.
30. Binkley PF, Cooke GE, Lesinski A, et al. Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events. PLoS One 2013;8:e54008.
31. Magnoni M, Malnati M, Cristell N, et al. Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability. J Med Virol 2012;84:1961-6.
32. Tufano A, Di Capua M, Coppola A, et al. The infectious burden in atherothrombosis. Semin Thromb Hemost 2012;38:515-23.